Skip to main content
. Author manuscript; available in PMC: 2012 Aug 6.
Published in final edited form as: Stroke. 2011 Apr 14;42(6):1581–1588. doi: 10.1161/STROKEAHA.110.607994

Figure 1. Capillary telangiectasia.

Figure 1

A–C, Axial T1- (A), T2- (B), and susceptibility-weighted images (C) obtained before, after gadoteridol, 25 minutes, and 24 hours after ferumoxytol administration. The gadoteridol and the 24-hour ferumoxytol T1-weighted MRI show a faint enhancing lesion in the pons (arrow). The capillary telangiectasia is isointense on the T2-weighted ferumoxytol images at 24 hours. The lesion demonstrates prominent signal loss on the susceptibility-weighted ferumoxytol scans.

HHS Vulnerability Disclosure